Marinus Pharmaceuticals reported -23485000 in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -43709000 23.06M
ALKERMES ALKS:US 4.42M 20.85M
Amgen AMGN:US $ 2333M 204M
Aptinyx Inc APTX:US $ -19866000 5.58M
Arena Pharmaceuticals ARNA:US $ -144391000 12.4M
Biogen BIIB:US $ 1030.1M 12.3M
Eisai 4523:JP 55.41B 61.33B
Esperion Therapeutics ESPR:US $ -32533000 50.29M
Gilead Sciences GILD:US $ 2262M 639M
Intercept Pharmaceuticals ICPT:US $ 511K 29.7M
Intra Cellular Therapies ITCI:US $ -69141060 15.92M
Marinus Pharmaceuticals MRNS:US -23485000 3.68M
Minerva Neurosciences NERV:US $ -8963290 1.46M
Neurocrine Biosciences NBIX:US $ 67.8M 36.3M
Ptc Therapeutics PTCT:US $ -98493000 345K
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sarepta Therapeutics SRPT:US $ -167574000 25.71M
Supernus Pharmaceuticals SUPN:US $ 34.11M 20.9M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M
YTE INCY:US $ 155.31M 40.5M
Zogenix ZGNX:US $ -55431000 3.63M